Three capabilities: research and development, safety measures, and a diversified supply chain define why Amneal Pharmaceuticals can bring high-quality generics, specialty, and biosimilar medicines to market faster, safer, and more cost-efficiently.

Amneal is one of the largest growing generic pharmaceutical manufacturers in the United States, with a broad portfolio of more than 250 pharmaceutical products providing patients with affordable, high-quality medicines. The team develops and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a broad range of therapeutic categories. Many generics represent difficult-to-manufacture products or products with a high barrier-to-entry, such as oncologics, anti-infectives, and supportive care to healthcare providers.

Amneal’s specialty business offers neurologists, movement disorder specialists, endocrinologists, and primary care physicians a portfolio in core therapeutic categories, including central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas.

Pharmacies and healthcare institutions throughout the U.S. and Puerto Rico know that Amneal Pharmaceutical means an unwavering commitment to quality, service, and value.